Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Origo Acquisition Corp | Financial_Report.xls |
| 10-K - 10-K - Origo Acquisition Corp | s100792_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - Origo Acquisition Corp | s100792_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Origo Acquisition Corp | s100792_ex31-2.htm |
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of CB Pharma Acquisition Corp. (the “Company”) on Form 10-K for the year ended November 30, 2014 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
Date: February 27, 2015
| /s/ Lindsay A. Rosenwald | |||
| Name: | Lindsay A. Rosenwald | ||
| Title: | Chief Executive Officer | ||
| (Principal Executive Officer) | |||
Date: February 27, 2015
| /s/ George C. Avgerinos | |||
| Name: | George C. Avgerinos | ||
| Title: | Chief Operating Officer | ||
|
(Principal Financial and Accounting Officer) | |||